Neurolipidomics: challenges and developments

被引:81
作者
Han, Xianlin [1 ]
机构
[1] Washington Univ, Sch Med, Dept Med, Div Bioorgan Chem & Mol Pharmacol, St Louis, MO 63110 USA
关键词
Alzheimer's disease; apolipoprotein E; ceramide; C-13; deisotoping; isotopomer; electrospray ionization; lipidome; lipidomics; mass spectrometry; multi-dimensional mass spectrometry; neurolipidomics; phospholipids; plasmalogen; sphingolipids; shotgun lipidomics; sulfatide; review;
D O I
10.2741/2258
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The field of lipidomics is one of the most rapidly expanding areas of systems biology research. Considering the uniqueness and complexity of the lipidome in the nervous system ( i.e., neurolipidome), neurolipidomics remains quite challenging but exciting. With the recent development of mass spectrometry ( MS)-based lipidomics, particularly the rapid improvement of multi-dimensional MS-based shotgun lipidomics, much progress has been made in neurolipidomics. As the accelerated development of future technologies enables lipidomics penetrance into lower and lower abundance regions of mass contents of individual lipid molecular species, it can be anticipated that many biochemical mechanisms underlying lipid metabolism critical to neuronal disease states will be increasingly uncovered. Through exploiting the information content inherent in the complexity of neuronal lipid composition and kinetic turnover which can be revealed by neurolipidomics, substantial insights into neuronal plasticity and gene function can be gathered. Through neurolipidomics, the markers for these neuronal diseases which identify pathological alterations and are diagnostic of disease onset, progression or severity may potentially be discovered. Accordingly, with neurolipidomics, our understanding of the complexities of the nervous system will be undoubtedly accelerated, as many mysteries are resolved.
引用
收藏
页码:2601 / 2615
页数:15
相关论文
共 73 条
[1]  
[Anonymous], 1995, METABOLIC MOL BASES
[2]  
[Anonymous], BRAIN ATLAS VISUAL G
[4]   Galactosphingolipids and axono-glial interaction in myelin of the central nervous system [J].
Bosio, A ;
Büssow, H ;
Adam, J ;
Stoffel, W .
CELL AND TISSUE RESEARCH, 1998, 292 (02) :199-210
[5]   Quantitative analysis of biological membrane lipids at the low picomole level by nano-electrospray ionization tandem mass spectrometry [J].
Brugger, B ;
Erben, G ;
Sandhoff, R ;
Wieland, FT ;
Lehmann, WD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (06) :2339-2344
[6]  
Cheng H, 2003, CELL MOL BIOL, V49, P809
[7]   Abundance of triacylglycerols in ganglia and their depletion in diabetic mice: implications for the role of altered triacylglycerols in diabetic neuropathy [J].
Cheng, Hua ;
Guan, Shaoping ;
Han, Xianlin .
JOURNAL OF NEUROCHEMISTRY, 2006, 97 (05) :1288-1300
[8]  
Coetzee T, 1998, J NEUROSCI RES, V54, P613, DOI 10.1002/(SICI)1097-4547(19981201)54:5<613::AID-JNR6>3.0.CO
[9]  
2-V
[10]  
Costantini Claudio, 2005, Alzheimers Dement, V1, P43, DOI 10.1016/j.jalz.2005.06.004